1. Home
  2. CALC vs HUDI Comparison

CALC vs HUDI Comparison

Compare CALC & HUDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • HUDI
  • Stock Information
  • Founded
  • CALC 2011
  • HUDI 2018
  • Country
  • CALC United States
  • HUDI China
  • Employees
  • CALC N/A
  • HUDI N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • HUDI Steel/Iron Ore
  • Sector
  • CALC Health Care
  • HUDI Industrials
  • Exchange
  • CALC Nasdaq
  • HUDI Nasdaq
  • Market Cap
  • CALC 20.9M
  • HUDI 18.8M
  • IPO Year
  • CALC N/A
  • HUDI 2021
  • Fundamental
  • Price
  • CALC $1.91
  • HUDI $1.49
  • Analyst Decision
  • CALC Strong Buy
  • HUDI
  • Analyst Count
  • CALC 3
  • HUDI 0
  • Target Price
  • CALC $16.33
  • HUDI N/A
  • AVG Volume (30 Days)
  • CALC 33.2K
  • HUDI 13.6K
  • Earning Date
  • CALC 05-14-2025
  • HUDI 05-23-2025
  • Dividend Yield
  • CALC N/A
  • HUDI N/A
  • EPS Growth
  • CALC N/A
  • HUDI N/A
  • EPS
  • CALC N/A
  • HUDI 0.01
  • Revenue
  • CALC N/A
  • HUDI $74,270,429.00
  • Revenue This Year
  • CALC N/A
  • HUDI N/A
  • Revenue Next Year
  • CALC N/A
  • HUDI N/A
  • P/E Ratio
  • CALC N/A
  • HUDI $156.78
  • Revenue Growth
  • CALC N/A
  • HUDI N/A
  • 52 Week Low
  • CALC $1.43
  • HUDI $1.27
  • 52 Week High
  • CALC $6.02
  • HUDI $3.45
  • Technical
  • Relative Strength Index (RSI)
  • CALC 56.52
  • HUDI 55.55
  • Support Level
  • CALC $1.86
  • HUDI $1.36
  • Resistance Level
  • CALC $2.04
  • HUDI $1.51
  • Average True Range (ATR)
  • CALC 0.14
  • HUDI 0.13
  • MACD
  • CALC 0.05
  • HUDI 0.02
  • Stochastic Oscillator
  • CALC 64.79
  • HUDI 85.19

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

Share on Social Networks: